| Literature DB >> 35255853 |
Maximilian Meyer1, Bernd Rist2, Johannes Strasser3, Undine E Lang3,4, Marc Vogel3, Kenneth M Dürsteler3,5, Marc Walter4,6.
Abstract
BACKGROUND: Heroin-assisted treatment has proven effective in reducing criminal offenses in opioid dependent individuals. Few studies attempted to explain the observed crime reduction and the reasons why these patients keep offending and getting incarcerated have to date not been explored.Entities:
Keywords: Crime; Criminal offense; Delinquency; Imprisonment; Interview; Opioid agonist treatment; Opioid use disorder; Qualitative study
Mesh:
Substances:
Year: 2022 PMID: 35255853 PMCID: PMC8903629 DOI: 10.1186/s12888-022-03814-5
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Interview guide
| Opening question |
| This interview is about your previous experiences with the penal system, with prisons to be precise. I now ask you to recall the time that led to you having to serve a prison sentence. (Pause) In the next minutes, can you tell me about this time in your life, giving as much detail as possible about how it came about that you had to go to prison? |
| Follow-up questions (ask if no narrative emerges) |
| Why did you have to serve a prison sentence? |
| What would have had to be different in your life to avoid a prison sentence? |
| Do you think it is likely that you will have to go to prison again in your life? (Why? Why not?) |
Sample characteristics (n = 22)
| % | M | SD | |||
|---|---|---|---|---|---|
| Sociodemographic characteristics | |||||
| Sex | female | 3 | 13.6 | ||
| male | 19 | 86.4 | |||
| Age | 45.14 | 6.94 | |||
| Nationality | Switzerland | 17 | 77.3 | ||
| Other | 5 | 22.7 | |||
| Living situation | rented apartment | 12 | 54.5 | ||
| care home | 8 | 36.4 | |||
| assisted living | 2 | 9.1 | |||
| Source of income | social welfare | 12 | 54.5 | ||
| invalidity insurancea | 10 | 45.5 | |||
| employment | - | - | |||
| Relationship status | single | 11 | 50.0 | ||
| in a relationship | 10 | 45.5 | |||
| divorced | 1 | 4.5 | |||
| Treatment variables | |||||
| Length of treatment in the centre | < 1 year | - | - | ||
| 1–5 years | 9 | 40.9 | |||
| 6–10 years | 5 | 22.7 | |||
| 11–15 years | 4 | 18.2 | |||
| 16–20 years | 2 | 9.1 | |||
| > 20 years | 2 | 9.1 | |||
| Psychiatric medication at the time of study conduction | diacetylmorphine | 21 | 95.5 | ||
| morphine-sulfate | 19 | 86.4 | |||
| methadone | 2 | 9.1 | |||
| levomethadone | 1 | 4.5 | |||
| benzodiazepines | 13 | 59.1 | |||
| stimulants | 4 | 18.2 | |||
| Route of DAM administration | intravenous | 10 | 45.5 | ||
| oral | 6 | 27.3 | |||
| oral and intravenous | 5 | 22.7 | |||
| not applicableb | 1 | 4.5 | |||
| Psychiatric disorders (lifetime prevalence as documented in the patient file) | |||||
| Opioid Use Disorder | 22 | 100 | |||
| Cocaine Use Disorder | 21 | 95.5 | |||
| Alcohol Use Disorder | 8 | 36.4 | |||
| Sedative, Hypnotic and Anxiolytic Use Disorder | 7 | 31.8 | |||
| Personality Disorders | 5 | 22.7 | |||
| Cannabis Use Disorder | 4 | 18.2 | |||
| ADHD | 4 | 18.2 | |||
| Major Depression | 4 | 18.2 | |||
| Schizophrenia | 3 | 13.6 | |||
| Anxiety Disorders | 2 | 9.1 | |||
| Disruptive Mood Dysregulation Disorder | 1 | 4.5 | |||
| Bipolar Disorder | 1 | 4.5 | |||
a Patients receiving insurance income due to psychiatric disability
b One patient had stopped their DAM prescription at the time of study conduction but had received DAM during the time of their incarceration;
Fig. 1Main categories